| Literature DB >> 21391896 |
Beiyi Liu1, Xiaorui Hou, Qiugen Zhou, Jianwei Tian, Ping Zhu, Jie Xu, Fanfan Hou, Ning Fu.
Abstract
Advanced oxidation protein products (AOPP) as a biomarker of oxidative stress has been demonstrated in chronic kidney disease (CKD) patients; however, current methods to detect the accumulation of AOPP in serum and in tissues are limited and unreliable. This study generated a monoclonal antibody (mAb) designated 3F2, that reacts specifically with hypochlorous acid (HOCl)-modified proteins, but not with the native forms or with other types of oxidative modifications. Notably, mAb 3F2 recognizes the AOPP deposited in renal tissues of AOPP-treated rats and of patients with different kinds of CKD. Moreover, this mAb can almost completely inhibit the production of reactive oxygen species in RAW264.7 cells induced by AOPP (p < 0.001). In conclusion, mAb 3F2 can be used to detect AOPP specifically in serum and in tissues, and this antibody can potentially provide an important tool and new insight into research on diseases related to oxidative stress.Entities:
Mesh：
Substances：
Year: 2011 PMID： 21391896 DOI： 10.3109/10715762.2011.564167
Source DB: PubMed Journal: Free Radic Res ISSN： 1029-2470